A Look At Avantor (AVTR) Valuation After A Year Of Weak Shareholder Returns

Simply Wall St.

20 hours ago

Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2612928299"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612928299\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612928299?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-02-20 02:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612928299","market":"us","top_or_hot":-1,"title":"A Look At Avantor (AVTR) Valuation After A Year Of Weak Shareholder Returns","media":"Simply Wall St.","content":"<div>\n<p>Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/a-look-at-avantor-avtr-valuation-after-a-year-of-weak-shareh\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Avantor (AVTR) Valuation After A Year Of Weak Shareholder Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Avantor (AVTR) Valuation After A Year Of Weak Shareholder Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-20 02:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/a-look-at-avantor-avtr-valuation-after-a-year-of-weak-shareh><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/a-look-at-avantor-avtr-valuation-after-a-year-of-weak-shareh\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVTR","symbol_name":"Avantor, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/a-look-at-avantor-avtr-valuation-after-a-year-of-weak-shareh","article_id":"2612928299","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/a-look-at-avantor-avtr-valuation-after-a-year-of-weak-shareh","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2612928299","pubTimestamp":1771525557,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward profile.\nSee our latest analysis for Avantor.\nDespite a 2.43% 1 day share price gain, Avantor’s 30 day share price return of a 23.77% decline and 1 year total shareholder return of a 47.57% loss point to fading momentum and a tougher recent backdrop for investors.\nIf Avantor’s recent swings have you...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVTR":"Avantor, Inc.","BK4121":"生命科学工具和服务"},"translate_title":"经过一年股东回报疲软后审视Avantor(AVTR)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVTR":1.5},"content_text":"Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward profile. See our latest analysis for Avantor. Despite a 2.43% 1 day share price gain, Avantor’s 30 day share price return of a 23.77% decline and 1 year total shareholder return of a 47.57% loss point to fading momentum and a tougher recent backdrop for investors. If Avantor’s recent swings have you reassessing your options, this could be a good moment to look at 25 healthcare AI stocks as potential next ideas to research. With Avantor trading at US$9.27, carrying a value score of 5 and flagged with an intrinsic discount of about 43%, the key question is whether this signals a genuine opportunity or if the market already reflects its future growth. AdvertisementMost Popular Narrative: 28.9% Undervalued Avantor’s most followed narrative pegs fair value at about $13.04 versus the last close of $9.27, setting up a clear valuation gap that hinges on execution and future cash flows.  The continued acceleration of biologics, gene therapies, and personalized medicine creates an increasing need for specialized and single-use solutions, an area where Avantor is investing in market-leading platforms and expanding innovation. This is positioning the company to benefit from secular end-market growth and product mix shift toward higher-margin segments, supporting margin and earnings growth.  Read the complete narrative. Curious what kind of revenue trajectory and margin rebuild would need to underpin that fair value, and how earnings power is expected to evolve from here, the full narrative lays out those assumptions in plain numbers and connects them to a valuation that sits above today’s price. Result: Fair Value of $13.04 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still a real chance that weaker bioprocessing demand, tighter pricing, and elevated leverage could slow any earnings rebuild and challenge that undervalued thesis. Find out about the key risks to this Avantor narrative. Next Steps Given the mix of concerns and optimism in this story, it makes sense to look at the numbers yourself and move quickly to form your own view. You can ground that view in 3 key rewards and 1 important warning sign. Looking for more investment ideas? If Avantor’s setup has you thinking about where else to put fresh research time, do not stop here. Widen your net with a few focused angles.  Target income first and let price be a follow up consideration by reviewing our list of 13 dividend fortresses that might suit a yield focused watchlist. Hunt for potential mispricings by scanning 53 high quality undervalued stocks where quality and valuation filters work together to surface candidates for deeper research. Prioritize resilience and sleep better at night by reviewing 80 resilient stocks with low risk scores that score well on financial strength and lower risk profiles.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}